Crossmark

Supplemental thiamine for the treatment of acute heart failure syndrome: a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s12906-019-2506-8

Published Online: 2019-05-06

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Smithline, Howard A. http://orcid.org/0000-0001-6972-5833
Donnino, Michael

Blank, Fidela S. J.

Barus, Richard

Coute, Ryan A.

Knee, Alexander B.

Visintainer, Paul
Funding

Funding for this research was provided by:

Baystate Health
License Information

Text and Data Mining valid from 2019-05-06
More Information

Article History

Received: 29 October 2018

Accepted: 16 April 2019

First Online: 6 May 2019

Ethics approval and consent to participate

: The human ethics committee of both hospitals approved this study. Specifically, this study was approved by the Institutional Review Board of the Human Research Protection Program at Baystate Medical Center, and the Institutional Review Board of the Human Subjects Protection Office at Beth Israel Deaconess Medical Center. All subjects consented to be in this study and signed approved consent documents.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.